There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
Other approaches that are in development include fibroblast growth factor (FGF) mimetics such as FGF21-targeting candidates ...
A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...
These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...
Can Ozempic and similar drugs cause muscle and bone loss? Discover how to maintain your health while achieving weight loss ...
As we have entered into the new year 2025, here's a recap of 2024's economy and healthcare with key areas to look in global ...